Norway· NO-ID_A8638ADF-52EA-4915-89ED-FD9BCBAA007B

Vemlidy

A tenofovir alafenamide product containing tenofovir alafenamide, registered in Norway by Abacus Medicine A/S. The same ATC class is registered in 14 of our 19 countries.

ATC J05AF13

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedVemlidyATCJ05AF13REGISTER NO.NO-ID_A8638ADF-52EA-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Tenofovir alafenamide is registered in 14 of 19 countries.

Countries holding a registration under ATC J05AF13 (tenofovir alafenamide), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose

Tenofovir alafenamide · ATC J05AF13

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tenofovir alafenamide costs, country by country.

Normalised to the WHO defined daily dose (25 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Tenofovir alafenamide · price per daily dose (25 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$20.29
  • IT Italy$18.37
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Tenofovir Alafenamide
Manufacturer
Abacus Medicine A/S
Country
Norway (NO)
ATC code
J05AF13
ATC class
Tenofovir alafenamide
Defined daily dose
25 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_A8638ADF-52EA-4915-89ED-FD9BCBAA007B
  • no_varenummer
    420494
    30
    NOK 4932.3
  • gtin
    5712440014275

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tenofovir alafenamide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tenofovir alafenamide products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Germany · Tenofoviralafenamid Devatis
  • Iceland · Vemlidy
  • Liechtenstein · Vemlidy
  • Netherlands · Tenofoviralafenamide Devatis
  • Portugal · Tenofovir Alafenamida Humanis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5d0ec89a-32e4-4d65-8a34-7fa46d0494e1
GET /v1/drugs/5d0ec89a-32e4-4d65-8a34-7fa46d0494e1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett, filmdrasjert",
  "source": "fest",
  "status": "A",
  "atc_name": "Tenofoviralafenamid",
  "merkevare_id": "ID_A8638ADF-52EA-4915-89ED-FD9BCBAA007B",
  "name_form_strength": "Vemlidy tab 25 mg",
  "prescription_group": "C"
}

See everything about tenofovir alafenamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.